Previously, meta-analysis conducted by Binabaj et al. illustrated that the upregulation of CCND1 was tightly linked to poor prognosis in patients with head and neck cancer and could be a potential prognostic marker for this cancer type [24]. Here, CCND1 is linked to head and neck cancer.